Fernando Q Cunha Selected Research

hesperidin methylchalcone

6/2018

Hesperidin Methylchalcone Suppresses Experimental Gout Arthritis in Mice by Inhibiting NF-κB Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fernando Q Cunha Research Topics

Disease

69	Inflammation (Inflammations) 08/2022 - 10/2002
54	Pain (Aches) 01/2022 - 04/2002
51	Hyperalgesia 04/2021 - 04/2002
42	Infections 01/2022 - 07/2003
42	Sepsis (Septicemia) 01/2022 - 02/2005
36	Arthritis (Polyarthritis) 01/2022 - 08/2004
17	Edema (Dropsy) 12/2020 - 07/2006
13	Neoplasms (Cancer) 01/2021 - 07/2006
13	Experimental Arthritis 01/2017 - 07/2003
13	Necrosis 04/2015 - 08/2004
12	Peritonitis 05/2021 - 01/2003
12	Rheumatoid Arthritis 01/2018 - 06/2006
10	Neuralgia (Stump Neuralgia) 01/2020 - 11/2014
8	COVID-19 10/2022 - 01/2021
7	Gout 01/2022 - 02/2012
7	Septic Shock (Toxic Shock Syndrome) 11/2018 - 09/2007
6	Hypersensitivity (Allergy) 08/2019 - 10/2002
6	Bacteremia 04/2019 - 02/2006
6	Mucositis 11/2016 - 04/2008
5	Pneumonia (Pneumonitis) 05/2021 - 07/2003
5	Chagas Disease (American Trypanosomiasis) 01/2020 - 04/2004
5	Bone Resorption 12/2018 - 02/2009
5	Alveolar Bone Loss 09/2017 - 02/2009
4	Autoimmune Diseases (Autoimmune Disease) 08/2022 - 07/2003
4	Periodontitis 10/2019 - 02/2009
4	Periodontal Diseases (Periodontal Disease) 10/2019 - 02/2009
4	Diarrhea 11/2016 - 04/2008
4	Hemorrhage 12/2015 - 09/2007
4	Wounds and Injuries (Trauma) 01/2014 - 09/2004
3	Asthma (Bronchial Asthma) 04/2020 - 07/2003
3	Synovitis 03/2020 - 09/2015
3	Chronic Pain 05/2019 - 03/2010

Drug/Important Bio-Agent (IBA)

80	CytokinesIBA 08/2022 - 10/2002
27	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2002
25	AntigensIBA 01/2022 - 07/2007
23	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2021 - 04/2002
16	CarrageenanIBA 08/2019 - 10/2002
15	ChemokinesIBA 01/2020 - 03/2005
13	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2003
13	Analgesics (Analgesic Drugs)IBA 01/2019 - 11/2009
13	Peroxidase (Myeloperoxidase)IBA 01/2017 - 07/2006
11	Interleukin-17 (Interleukin 17)IBA 08/2022 - 04/2009
11	Interleukin-33IBA 01/2022 - 06/2010
11	Interleukin-10 (Interleukin 10)IBA 12/2021 - 04/2008
11	LipopolysaccharidesIBA 04/2019 - 07/2003
10	Messenger RNA (mRNA)IBA 01/2022 - 03/2009
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2007
10	LigandsIBA 01/2019 - 07/2005
9	Interleukin-18 (Interleukin 18)IBA 01/2021 - 07/2003
9	ProstaglandinsIBA 01/2020 - 05/2007
9	InterleukinsIBA 03/2015 - 01/2003
8	methylated bovine serum albumin (MBSA)IBA 01/2022 - 04/2008
8	InflammasomesIBA 01/2022 - 02/2012
8	Superoxides (Superoxide)IBA 12/2020 - 07/2015
8	Type I Tumor Necrosis Factor ReceptorsIBA 02/2017 - 06/2009
8	Endothelins (Endothelin)IBA 01/2017 - 11/2005
8	ZymosanIBA 08/2016 - 12/2004
8	Leukotriene B4IBA 02/2015 - 07/2003
7	Dinoprostone (PGE2)FDA Link 04/2021 - 07/2008
7	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2016 - 01/2011
7	Interleukin-1beta (Interleukin 1 beta)IBA 06/2015 - 08/2004
6	EnzymesIBA 10/2019 - 08/2010
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 11/2009
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018 - 04/2004
6	KATP ChannelsIBA 08/2017 - 05/2005
6	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2015 - 06/2009
5	Phosphotransferases (Kinase)IBA 12/2021 - 09/2010
5	OvalbuminIBA 04/2020 - 08/2005
5	Chemokine ReceptorsIBA 01/2018 - 03/2009
5	Pharmaceutical PreparationsIBA 11/2015 - 04/2008
5	salicylhydroxamic acid (SHAM)IBA 04/2015 - 11/2004
5	Pentoxifylline (Trental)FDA LinkGeneric 02/2015 - 08/2004
5	LipidsIBA 02/2015 - 03/2010
5	LeukotrienesIBA 01/2013 - 02/2005
4	Uric Acid (Urate)IBA 12/2020 - 01/2018
4	Etanercept (Enbrel)FDA Link 05/2019 - 04/2014
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2019 - 02/2012
4	budlein AIBA 01/2018 - 05/2007
4	Acetic Acid (Vinegar)FDA LinkGeneric 07/2017 - 12/2004
4	NitratesIBA 07/2017 - 02/2006
4	Interleukin-1 (Interleukin 1)IBA 11/2016 - 02/2008
4	Irinotecan (Camptosar)FDA LinkGeneric 11/2016 - 04/2008
4	Morphine (MS Contin)FDA LinkGeneric 02/2015 - 11/2005
4	Indomethacin (Indometacin)FDA LinkGeneric 02/2015 - 10/2002
4	Thalidomide (Thalomid)FDA Link 02/2015 - 08/2004
4	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2013 - 02/2005
3	Therapeutic UsesIBA 12/2021 - 01/2015
3	Opioid Analgesics (Opioids)IBA 01/2020 - 04/2011
3	Type II Tumor Necrosis Factor ReceptorsIBA 05/2019 - 09/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2019 - 02/2008
3	potassium superoxideIBA 01/2019 - 09/2015
3	Biomarkers (Surrogate Marker)IBA 11/2018 - 01/2013
3	Antineoplastic Agents (Antineoplastics)IBA 10/2018 - 09/2011
3	FlavonoidsIBA 06/2018 - 08/2017
3	PPAR gammaIBA 01/2018 - 01/2008
3	15-deoxyprostaglandin J2IBA 01/2018 - 01/2008

Therapy/Procedure

28	Ligation 01/2022 - 02/2005
23	Punctures 01/2022 - 02/2005
15	Therapeutics 01/2020 - 11/2005
4	Drug Therapy (Chemotherapy) 12/2015 - 05/2006